Erythropoietin receptor on cDC1s dictates immune tolerance.

Saved in:
Bibliographic Details
Title: Erythropoietin receptor on cDC1s dictates immune tolerance.
Authors: Zhang X; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA. xiangyue@stanford.edu., McGinnis CS; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Yu G; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Chen S; Department of Genetics, School of Medicine, Stanford University, Palo Alto, CA, USA., Zheng P; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, School of Medicine, Stanford University, Palo Alto, CA, USA., Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Hiam-Galvez KJ; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Reticker-Flynn NE; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Stanford University, Stanford, CA, USA., Guo W; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Yao W; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Qiu J; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Muselman A; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Linde IL; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Hickey JW; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Yan H; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, School of Medicine, Stanford University, Palo Alto, CA, USA., Tran VM; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Qiu W; Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Brichart-Vernos D; CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France., Hirai T; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, School of Medicine, Stanford University, Palo Alto, CA, USA., Yu B; ImmunEdge, Redwood City, CA, USA., An X; Laboratory of Membrane Biology, New York Blood Center, New York, NY, USA., Xiao Y; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Paidassi H; CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France., Scharschmidt TC; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Angelo M; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA., Sheppard D; Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Chi H; Department of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA., Satpathy AT; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Way SS; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Malissen B; Centre d'Immunologie de Marseille-Luminy, Aix-Marseille Université, INSERM, CNRS, Marseille, France., Strober S; Department of Medicine (Immunology and Rheumatology), School of Medicine, Stanford University, Palo Alto, CA, USA., Engleman EG; Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA. edgareng@stanford.edu.; Stanford Cancer Institute, School of Medicine, Stanford University, Palo Alto, CA, USA. edgareng@stanford.edu.
Source: Nature [Nature] 2026 Feb; Vol. 650 (8101), pp. 470-480. Date of Electronic Publication: 2025 Dec 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-025-09824-z